Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen, Agilent to Co-Market Pathogen-Detection System ...

NEW YORK, April 7 (GenomeWeb News) - Invitrogen and Agilent Technologies today announced a two-year agreement to co-market the PathAlert System, a technology that combines Invitrogen reagents and Agilent's 2100 bioanalyzer or 5100 Automated Lab-on-a-Chip platforms.

 

Invitrogen will distribute the PCR-based technology, which as been successfully evaluated by the US Department of Defense and the Environmental Protection Agency, the companies said.

The news comes one day after the US government held a hearing to discuss ways in which the different agencies responsible for overseeing pathogen detection can work together more effectively. As reported by GenomeWeb News publication Pharmacogenomics Reporter this week, the outcome of this hearing could benefit companies developing pathogen-detection technologies, such as Cepheid, CombiMatrix, and now Invitrogen and Agilent.

 

By testing samples collected from the air, food, and water, the system may be used to detect infectious agents such as Bacillus anthracis, which causes anthrax; Yersinia pestis, which causes plague; Vaccinia, which causes smallpox simulant; and Francisella tularensis, which causes tularemia.

 

Financial details of the collaboration were not disclosed.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.